Global Chemotherapy Market Segments 2024, Forecast To 2033
5 Mar, 2024
The chemotherapy market size surged from $30.89 billion in 2023 to $34.38 billion in 2024, with an 11.3% CAGR, attributed to increased cancer incidence, drug development innovations, and awareness campaigns. Expected to grow to $54.86 billion in 2028, the forecast period highlights immunotherapy integration, biosimilar adoption, and regulatory facilitation. Major trends include digital health solutions, personalized medicine, and home-based chemotherapy administration, reflecting advancements in nanotechnology and oncology research.
Global Chemotherapy Market Key Driver
The increasing cancer prevalence is driving the growth of the chemotherapy market. With a projected rise in new cancer cases, chemotherapy remains a critical treatment option. The growing need for effective cancer therapies is a major factor propelling the growth of the chemotherapy market.
Get A Free Sample Of The Global Chemotherapy Market ReportGlobal Chemotherapy Market Segments
The chemotherapy market covered in this report is segmented –
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North Americawas the largest region in the chemotherapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Chemotherapy Industry Players
GlaxoSmithKline plc; Eli Lilly and Company; F. Hoffmann-La Roche Ltd.; Novartis AG; Pfizer Inc.; Merck & Co Inc.; Sanofi SA; Celgene Corporation; Bristol-Myers Squibb Company; Amgen Inc.; Bayer AG; Almatic Pharma LLC; AstraZeneca Pharmaceuticals; Astellas Pharma Inc.; Puma Biotechnology Inc.; Clovis Oncology Inc.; Takeda Pharmaceutical Company Limited; Johnson & Johnson Services Inc.; Mylan NV; Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Gilead Sciences Inc.; Biogen Inc.; Eisai Co. Ltd.; Ipsen SA; Spectrum Pharmaceuticals Inc.; Seattle Genetics Inc.; Exelixis Inc.; Karyopharm Therapeutics Inc.; Incyte Corporation; Agios Pharmaceuticals Inc.; Epizyme Inc.; Blueprint Medicines Corporation; Array BioPharma Inc.; BeiGene Ltd.; Halozyme Therapeutics Inc.; MacroGenics Inc.; Immunomedics Inc.; TG Therapeutics Inc.; Verastem Inc.
Get The Full Global Chemotherapy Market ReportAIOps Chemotherapy Market Overview
Chemotherapy refers to a treatment using drugs or medicines that kill the fast-growing cells in the body by using powerful chemicals. The drugs can be used in combination or alone for the treatment of cancer. They are used to treat cancer, as cancer cells grow at a fast rate.
Chemotherapy Global Market Report 2023 provides data on the global chemotherapy market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The chemotherapy market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.